Docetaxel + KetoconazoleUnknown
In vivo studies showed that the exposure of docetaxel increased 2.2-fold when it was coadministered with ketoconazole, a potent inhibitor of CYP3A4.
Source: FDA drug label - docetaxel
Brand names: Docetaxel
2 interactions on record
In vivo studies showed that the exposure of docetaxel increased 2.2-fold when it was coadministered with ketoconazole, a potent inhibitor of CYP3A4.
Source: FDA drug label - docetaxel
Protease inhibitors, particularly ritonavir, may increase the exposure of docetaxel.
Source: FDA drug label - docetaxel